Mass drug administration targeting Onchocerca volvulus in Owabi catchment area in Ashanti Region, Ghana: Determinants of drug coverage and drug uptake.

Simple item page
dc.contributor.authorOsei Adjei Francis
dc.contributor.authorOsei-Yeboah Eugene
dc.contributor.authorOwusu-Dabo Ellis
dc.contributor.authorOdoom Frimpong Samuel
dc.contributor.authorNyarko Ofori Obed....et al
dc.date.accessioned2023-12-05T15:25:23Z
dc.date.available2023-12-05T15:25:23Z
dc.date.issued2021
dc.descriptionThis article is published by Elsevier and is also available at www.elsevier.com/locate/parepi
dc.description.abstractIntroduction: Achieving high Mass Drug Administration (MDA) coverage and drug uptake are pivotal in the efforts to eradicate onchocerciasis. The present study investigated the extent and predictors of ivermectin MDA coverage and uptake from the individual and healthcare providers’ perspectives. The extent of ivermectin distribution and uptake, and the predictors of distribution and uptake were investigated in endemic communities in the Ashanti Region of Ghana. Methods: A cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District. A total of 2008 respondents were interviewed. Data was collected with REDCap mobile App which had an electronic version of the structured questionnaire. Descriptive data was presented in frequency tables, and bivariate and multivariate logistics regression analysis were performed to measure the associations between exposure var iables and outcome variables which were received and uptake of MDA drugs. Results: A total of 1284 (63.9%) respondents did not receive ivermectin during the 2019 MDA programme and more than half of them were not aware of the drug distribution (53.3%). The most common reasons for not ingesting the drug were fear of side effects (47.7%) and not trusting the drug distributors (20.0%). Respondents in the age group 48–57 years (AOR = 1.37; 95%CI: 1.01–2.67), Persons in the high wealth index (AOR = 1.40; 95%CI: 1.11–1.77), Being aware of the MDA programme (AOR = 6.67: 95%CI: 4.76–9.35), MDA being beneficial (AOR = 2.12; 95%CI: 1.54–2.92) participating in previous MDA (AOR = 5.44; 95%CI: 4.25–6.98) and having stayed in the communities for 10 years and above significantly increased the odds of receiving MDA drugs. Previous uptake of MDA drugs (AOR = 10.58; 95%CI: 5.78–19.38) and perception of the MDA drug as beneficial (AOR = 5.25; 95%CI: 2.55–10.82) increased the likelihood of ingesting drugs when received.
dc.description.sponsorshipKNUST
dc.identifier.citationParasite Epidemiology and Control 16 (2022) e00235
dc.identifier.uri10.1016/j.parepi.2021.e00235
dc.identifier.urihttps://ir.knust.edu.gh/handle/123456789/14624
dc.language.isoen
dc.publisherELSEVIER
dc.titleMass drug administration targeting Onchocerca volvulus in Owabi catchment area in Ashanti Region, Ghana: Determinants of drug coverage and drug uptake.
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mass drug administration targeting Onchocerca volvulus in Owabi.pdf
Size:
467.24 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles